Search

everythinglearnresearchcommunity

for

Search:↓

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Mutations in certain receptors can cause diseases and offer new treatment options.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

A new gene variant causes glucocorticoid resistance in a mother and son.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

People with Parkinson's disease have higher levels of cortisone in their hair, which may indicate chronic stress hormone dysfunction.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Adrenal disorders often cause high blood pressure in young people.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.